De novo lipogenesis represents a therapeutic target in mutant Kras non‐small cell lung cancer-Reference-Cited by-同舟云学术

De novo lipogenesis represents a therapeutic target in mutant Kras non‐small cell lung cancer

Published:2018-06-15 Issue:12 Volume:32 Page:7018-7027
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Singh Anju¹,Ruiz Christian²,Bhalla Kavita³,Haley John A.²,Li Qing Kay⁴,Acquaah‐Mensah George⁵,Montal Emily²,Sudini Kuladeep R.¹,Skoulidis Ferdinandos⁶,Wistuba Ignacio I.⁶,Papadimitrakopoulou Vassiliki⁶,Heymach John V.⁶,Boros Laszlo G.⁷,Gabrielson Edward⁴,Carretero Julian⁸,Wong Kwok‐Kin⁹,Haley John D.²,Biswal Shyam¹,Girnun Geoffrey D.²

Affiliation:

1. Department of Environmental Health Sciences, Bloomberg School of Public HealthThe Johns Hopkins School of Medicine, Johns Hopkins UniversityBaltimore Maryland USA

2. Department of PathologyStony Brook School of MedicineStony Brook New York USA

3. Department of Biochemistry and Molecular BiologyUniversity of Maryland School ofMedicineBaltimoreMarylandUSA

4. Department of PathologyThe Johns Hopkins School of Medicine, Johns Hopkins UniversityBaltimore Maryland USA

5. Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins School of Medicine, Johns Hopkins UniversityBaltimore Maryland USA

6. University of Texas M.D. Anderson Cancer CenterHouston Texas USA

7. Stable Isotope‐Based Dynamic Metabolic Profiling (SiDMAP) LLCLos Angeles California USA

8. Department of PhysiologyUniversity of ValenciaValenciaSpain

9. Department of Medical OncologyDana Farber Cancer InstituteBostonMassachusettsUSA

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201800204

Reference50 articles.

1. K-ras Mutations in Non-Small-Cell Lung Carcinoma: A Review

2. ras oncogenes in human cancer: a review;Bos J. L.;Cancer Res.,1989

3. K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined analysis of 881 cases

4. The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

5. Targeting KRAS mutated non-small cell lung cancer: A history of failures and a future of hope for a diverse entity

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting fatty acid synthase in preclinical models of TNBC brain metastases synergizes with SN-38 and impairs invasion;npj Breast Cancer;2024-06-10

2. Emerging targets in lipid metabolism for cancer therapy;Trends in Pharmacological Sciences;2024-06

3. Novel artesunate-metformin conjugate inhibits bladder cancer cell growth associated with Clusterin/SREBP1/FASN signaling pathway;The Korean Journal of Physiology & Pharmacology;2024-05-01

4. Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non–Small Cell Lung Cancer;Cancer Research;2024-03-19

5. Vitamin‐C‐dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest;Molecular Oncology;2024-02-29